Industry NewsPositive results from Adrenomed’s AdrenOSS-2 Phase II trial evaluating Adrecizumab (HAM8101) in septic shock presented during e-ISICEM
Product NewsQIAGEN to launch rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen
Industry NewsERS Genomics announces agreement with Applied StemCell to commercialize CRISPR gene editing services and reagents